Journal: BMC Complementary and Alternative Medicine

Article Title: Relationship between total phenolic contents and biological properties of propolis from 20 different regions in South Korea

doi: 10.1186/s12906-016-1043-y

Figure Lengend Snippet: List of human intestinal bacteria tested for growth inhibitory activity

Article Snippet: B. infantis ATCC 25962 b , 2 , P12 (14.7), P19 (14.7), CF d (0.031).

Techniques:

Journal: BMC Complementary and Alternative Medicine

Article Title: Relationship between total phenolic contents and biological properties of propolis from 20 different regions in South Korea

doi: 10.1186/s12906-016-1043-y

Figure Lengend Snippet: Minimal inhibitory concentrations (MICs) of Korean propolis ethanol extracts and a commercial antibiotic ciprofloxacin toward four harmful and two nonpathogenic intestinal bacteria

Article Snippet: B. infantis ATCC 25962 b , 2 , P12 (14.7), P19 (14.7), CF d (0.031).

Techniques:

Journal: BMC Complementary and Alternative Medicine

Article Title: Relationship between total phenolic contents and biological properties of propolis from 20 different regions in South Korea

doi: 10.1186/s12906-016-1043-y

Figure Lengend Snippet: List of human intestinal bacteria tested for growth inhibitory activity

Article Snippet: The MIC of EEPs from P12 and P19 was 14.7 mg/mL toward B. infantis ATCC 25962 and 14.7 and 7.4 mg/mL toward C. butyricum ATCC 25779, respectively (ciprofloxacin, 0.031 mg/mL).

Techniques:

Journal: BMC Complementary and Alternative Medicine

Article Title: Relationship between total phenolic contents and biological properties of propolis from 20 different regions in South Korea

doi: 10.1186/s12906-016-1043-y

Figure Lengend Snippet: Minimal inhibitory concentrations (MICs) of Korean propolis ethanol extracts and a commercial antibiotic ciprofloxacin toward four harmful and two nonpathogenic intestinal bacteria

Article Snippet: The MIC of EEPs from P12 and P19 was 14.7 mg/mL toward B. infantis ATCC 25962 and 14.7 and 7.4 mg/mL toward C. butyricum ATCC 25779, respectively (ciprofloxacin, 0.031 mg/mL).

Techniques: